Amvis Holdings, Inc.
Notice Regarding Establishment of a Subsidiary
Established a new wholly owned subsidiary, AIZIA Inc. The subsidiary will support transformation of operational processes in medical and nursing care settings through DX and AI utilization. The purpose is to improve productivity and to develop and provide AI-utilizing systems. Capital is 1 yen, shareholding ratio is 100% by Amvis Holdings, Inc., and the scheduled establishment date is October 1, 2026. No impact on consolidated results for the current fiscal year.
Key Figures
- New subsidiary name: AIZIA Inc.
- Capital: 1 yen
- Shareholding ratio: 100% (Amvis Holdings, Inc.)
AI要約
Overview of the Newly Established Subsidiary
The Company resolved at the Board of Directors meeting to establish a wholly owned subsidiary, AIZIA Inc., for the purpose of developing and providing systems for medical and nursing care sites utilizing AI. AIZIA will support DX promotion in medical settings by leveraging on-site expertise to provide comprehensive services from system integration and operational process transformation to operational improvements. Capital is 1 yen, shareholding ratio is 100% by Amvis Holdings, Inc., the location is Chuo-ku, Tokyo, and the representative is Keiichi Shibahara. The establishment is scheduled for October 1, 2026.
Future Impact and Outlook
The subsidiary is scheduled to begin operations after October 2026, and there is currently no impact on the Company's consolidated results for the fiscal year ending September 2026. If any matter arises that would have a material impact on earnings, it will be disclosed promptly. The establishment of AIZIA is expected to expand the Group's DX and AI service offerings and strengthen on-site support.
Amvis Holdings, Inc.
Company overview · Stock price · Financial data · All IR
